Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Ob/gyn panel to review Corometrics petition seeking downclassification for preterm use HUAMs.

This article was originally published in The Gray Sheet

Executive Summary

COROMETRICS HOME UTERINE MONITOR RECLASSIFICATION REQUEST TO BE REVIEWED BY PANEL at an Oct. 7 meeting in Rockville, Maryland. FDA's Obstetrics and Gynecology Devices Panel will discuss Corometrics Medical Systems' petition to FDA seeking downclassification to Class II (special controls) for home uterine activity monitors intended for use in preterm monitoring (less than 36 weeks gestation). HUAMs for use in detection of preterm labor currently are Class III, requiring premarket approval; when used to monitor full-term pregnancy (after 36 weeks), HUAMs are regulated in Class II.
Advertisement
Advertisement
UsernamePublicRestriction

Register

MT008809

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel